Yaz studies sponsored by the FDA have shown an increased risk for severe disorders related to the cardiovascular system. The primary ingredient in this drug, drospirenone, is a synthetic hormone primarily used for birth control. However, it is also associated with elevated potassium levels due to its diuretic properties. This can result in heart attacks, strokes or fatal arrhythmias. As a result, thousands of Yaz injury lawsuits have been filed against Bayer, the drug’s manufacturer.
Drospirenone suppresses another hormone in the body, known as aldosterone. Aldosterone is an important regulatory substance in the body, and maintains proper balance of electrolytes, including potassium. The FDA has shown through several Yaz studies that this imbalance causes an extraordinarily high number of venous thromboembolisms. These are clots that form in blood veins and adhere to the vein wall or other surfaces in the body. Once this occurs, fluid obstruction is imminent, blocking blood flow to the heart or brain.
The FDA has also warned Bayer for misrepresentation in its ads. Many Yaz injury lawsuits have cited this warning as evidence of the company’s negligence. The agency chastised the company for overstating the benefits of the drug (suggesting that it could help with PMS symptoms, which was not proven) and understating the risks associated with it. Yaz studies performed by the FDA show a 93 percent higher risk of thrombotic events for women taking the drug for less than three months. Women who take it for more than seven months have a 290 percent increased risk of these complications.
Any woman who has taken drospirenone for birth control and suffered from major medical issues should think about contacting a lawyer that specializes in drug injury cases to review their options regarding compensation.